Contrast-enhanced MRI (cMRI) scans used to monitor patients with congenital heart disease (CHD) are frequently uncovering unexpected findings in the liver. While these scans are designed to evaluate cardiac structure and function, the imaging often captures incidental liver lesions, presenting clinicians with a complex diagnostic crossroads.
The Challenge of Incidental Findings
In medical imaging, an “incidental finding” occurs when a test performed for one reason reveals an unrelated abnormality. For patients with CHD, the cMRI is a vital tool for assessing the heart, but because the liver is often within the field of view, lesions can appear unexpectedly on the images.

The prevalence of these lesions in the CHD population suggests that they are a common occurrence during cardiac surveillance. However, the discovery of an unplanned liver lesion can shift the clinical focus from the heart to the abdomen, potentially introducing fresh anxieties for the patient and additional diagnostic burdens for the medical team.
The primary clinical tension lies in determining which lesions are benign and which require urgent intervention. Not every spot on an MRI is a cause for alarm, but the responsibility to rule out malignancy or serious pathology remains.
Clinical Context: The “Incidentaloma”
An “incidentaloma” is a term used by radiologists and clinicians to describe a mass found by chance during an imaging study for an unrelated condition. The challenge with incidentalomas is that they often lead to a cascade of follow-up tests, biopsies, or surgeries that may not have been necessary if the lesion was benign.
Navigating the Diagnostic Path
When a liver lesion is spotted during a cMRI for CHD, the next steps typically involve a careful analysis of the lesion’s characteristics. Radiologists glance for specific patterns in how the contrast agent moves through the lesion to help differentiate between common benign growths—such as hemangiomas or cysts—and more concerning masses.
Because these findings are common in this specific patient group, there is an ongoing need for clear protocols on how to manage them. Over-testing can lead to unnecessary invasive procedures, while under-testing could miss an early opportunity to treat a serious condition.
For patients and families, the appearance of an incidental liver lesion during a heart scan can be jarring. It transforms a routine cardiac check-up into a multi-organ investigation, highlighting the importance of clear communication between the cardiologist, the radiologist, and the patient regarding the likelihood of benign findings.
Implications for Care
The recognition that liver lesions are common in CHD patients undergoing cMRI encourages a more nuanced approach to imaging. Rather than treating every finding as an isolated emergency, clinicians are encouraged to integrate these results into the patient’s overall health profile, weighing the risks of further investigation against the characteristics of the lesion.
As imaging technology becomes more sensitive, the frequency of these incidental discoveries is likely to remain high, making the ability to distinguish clinically insignificant findings from those requiring action a critical skill in the management of CHD.
How can healthcare systems better prepare patients for the possibility of incidental findings during routine specialized imaging?



